Regulation of glutamate release by heteromeric nicotinic receptors in layer V of the secondary motor region (Fr2) in the dorsomedial shoulder of prefrontal cortex in mouse

Synapse

Volumn 67, Issue 6, 2013, Pages 338-357

  Aracri, Patrizia ^a   Amadeo, Alida ^b   Pasini, Maria Enrica ^b   Fascio, Umberto ^b   Becchetti, Andrea ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

2; 5IA85380; EPSC; Fr2; FrA; Heteromeric; M2; Nicotinic acetylcholine receptors; Premotor; VGLUT1; VGLUT2

Indexed keywords

ACONITINE DERIVATIVE; BUNGAROTOXIN RECEPTOR; DIHYDRO BETA ERYTHROIDINE; GLUTAMIC ACID; NICOTINIC RECEPTOR; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION; BEHAVIOR; CHEMICAL STRUCTURE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FRONTAL LOBE EPILEPSY; GENE MUTATION; HOMEOSTASIS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; INTERNEURON; MORPHOMETRICS; MOTOR CORTEX; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PYRAMIDAL NERVE CELL; SEIZURE; SOMATOSENSORY CORTEX; THALAMOCORTICAL TRACT;

ANIMALS; CEREBRAL CORTEX; EXCITATORY POSTSYNAPTIC POTENTIALS; GENE EXPRESSION; GLUTAMIC ACID; INTERNEURONS; MICE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; POST-SYNAPTIC DENSITY; PYRAMIDAL CELLS; RECEPTORS, NICOTINIC; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1; VESICULAR GLUTAMATE TRANSPORT PROTEIN 2;

EID: 84876431247     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21655     Document Type: Article

References (102)

1. Alkondon M, Pereira EF, Eisenberg HM, Albuquerque EX. 1999. Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices. J Neurosci 9:2693-2705.
2. Alkondon M, Pereira EF, Eisenberg HM, Albuquerque EX. 2000. Nicotinic receptor activation in human cerebral cortical interneurons: A mechanism for inhibition and dishinibition of neuronal networks. J Neurosci 20:66-75.
3. Aracri P, Consonni S, Morini R, Perrella M, Rodighiero S, Amadeo A, Becchetti A. 2010. Tonic modulation of GABA release by nicotinic acetylcholine receptors in layer V of the murine prefrontal cortex. Cereb Cortex 20:1539-1555.
4. Aridon P, Marini C, Di Resta C, Brilli E, De Fusco M, Politi F, Parrini E, Manfredi I, Pisano T, Pruna D, Curia G, Cianchetti C, Pasqualetti M, Becchetti A, Guerrini R, Casari G. 2006. Increased sensitivity of the neuronal nicotinic receptor α2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am J Hum Genet 79:342-350.
5. Azam L, Winzer-Serhan U, Leslie FM. 2003. Co-expression of α7 and β2 nicotinic acetylcholine receptor subunit mRNAs within rat brain cholinergic neurons. Neuroscience 119:965-977.
6. Bailey CD, De Biasi M, Fletcher PJ, Lambe EK. 2010. The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy. J Neurosci 30:9241-9252.
7. Bancila V, Cordeiro JM, Bloc A, Dunant Y. 2009. Nicotine-induced and depolarisation-induced glutamate release from hippocampus mossy fibre synaptosomes: Two distinct mechanisms. J Neurochem 110: 570-580.
8. Becchetti A. 2012. Neuronal nicotinic receptors in sleep-related epilepsy: Studies in integrative biology. ISRN Biochemistry 2012:1-26.
9. Bhattacharyya A, Bießmann F, Veit J, Kretz R, Rainer G. 2012. Functional and laminar dissociations between muscarinic and nicotinic cholinergic neuromodulation in the tree shrew primary visual cortex. Eur J Neurosci 35:1270-1280.
10. Berendse HW, Galis-de Graaf Y, Groenewegen HJ. 1992. Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat. J Comp Neurol 316:314-347.
11. Bolte S, Cordelières FP. 2006. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224:213-232.
12. Bravo H, Karten HJ. 1992. Pyramidal neurons of the rat cerebral cortex, immunoreactive to nicotinic acetylcholine receptors, project mainly to subcortical targets. J Comp Neurol 320:62-68.
13. Brown CE, Sweetnam D, Beange M, Nahirney PC, Nashmi R. 2012. α4* Nicotinic acetylcholine receptors modulate experience-based cortical depression in the adult mouse somatosensory cortex. J Neurosci 32:1207-1219.
14. Chang YM, Luebke JI. 2007. Electrophysiological diversity of layer 5 pyramidal cells in the prefrontal cortex of the rhesus monkey: In vitro slice studies. J Neurophysiol 98:2622-2632.
15. Christophe E, Roebuck A, Staiger JF, Lavery DJ, Charpak S, Audinat E. 2002. Two types of nicotinic receptors mediate an excitation of neocortical layer I interneurons. J Neurophysiol 88:1318-1327.
16. Condé F, Maire-Lepoivre E, Audinat E, Crepel F. 1995. Afferent connections of the medial frontal cortex of the rat. II Cortical and subcortical afferents. J Comp Neurol 352:567-593.
17. Connors BW, Gutnick MJ. 1990. Intrinsic firing patterns of diverse neocortical neurons. Trends Neurosci 13:99-104.
18. Couey JJ, Meredith RM, Spijker S, Poorthuis RB, Smit AB, Brussaard AB, Mansvelder HD. 2007. Distributed network actions by nicotine increase the threshold for spike-timing-dependent plasticity in prefrontal cortex. Neuron 54:73-87.
19. Dani JA, Bertrand D. 2007. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47:699-729.
20. DeFelipe J. 1997. Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. J Chem Neuroanat 14:1-19.
21. De Fusco M, Becchetti A, Patrignani A, Annesi G, Gambardella A, Quattrone A, Ballabio A, Wanke E, Casari G. 2000. The nicotinic receptor β2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 26:275-276.
22. Dickinson JA, Kew JN, Wonnacott S. 2008. Presynaptic α7- and β2-containing nicotinic acetylcholine receptors modulate excitatory amino acid release from rat prefrontal cortex nerve terminals via distinct cellular mechanisms. Mol Pharmacol 74:348-359.
23. Disney AA, Aoki C, Hawken MJ. 2007. Gain modulation by nicotine in macaque v1. Neuron 56:701-713.
24. Eyles DW, McGrath JJ, Reynolds GP. 2002. Neuronal calcium-binding proteins and schizophrenia. Schizophr Res 57:27-34.
25. Fenster CP, Rains MF, Noerager B, Quick MW, Lester RA. 1997. Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J Neurosci 17:5747-5759.
26. Franklin KJB, Chudasama Y. 2012. The prefrontal cortex. In: Watson C, Paxinos G, Puelles L, editors. The mouse nervous system. Amsterdam: Elsevier Academic Press. p 727-735.
27. Fujiyama F, Furuta T, Kaneko T. 2001. Immunocytochemical localization of candidates for vesicular glutamate transporters in the rat cerebral cortex. J Comp Neurol 435:379-387.
28. Gahring LC, Persiyanov K, Rogers SW. 2004. Neuronal and astrocyte expression of nicotinic receptor subunit beta4 in the adult mouse brain. J Comp Neurol 468:322-333.
29. Gil Z, Connors BW, Amitai Y. 1997. Differential regulation of neocortical synapses by neuromodulators and activity. Neuron 19:679-686.
30. Gioanni Y, Rougeot C, Clarke PB, Lepousè C, Thierry AH, Vidal C. 1999. Nicotinic receptors in the rat prefrontal cortex: Increase in glutamate release and facilitation of mediodorsal thalamo-cortical transmission. Eur J Neurosci 11:18-30.
31. Gonchar Y, Wang Q, Burkhalter A. 2008. Multiple distinct subtypes of GABAergic neurons in mouse visual cortex identified by triple immunostaining. Front Neuroanat 1:3.
32. Gotti C, Clementi F, Fornari A, Gaimarri A, Guiducci S, Manfredi I, Moretti M, Pedrazzi P, Pucci L, Zoli M. 2009. Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem Pharmacol 78:703-711.
33. Graziano A, Liu XB, Murray KD, Jones EG. 2008. Vesicular glutamate transporters define two sets of glutamatergic afferents to the somatosensory thalamus and two thalamocortical projections in the mouse. J Comp Neurol 507:1258-1276.
34. Guillem K, Bloem B, Poorthuis RB, Loos M, Smit AB, Maskos U, Spijker S, Mansvelder HD. 2011. Nicotinic acetylcholine receptor beta2 subunits in the medial prefrontal cortex control attention. Science 333:888-891.
35. Hahn B, Shoaib M, Stolerman IP. 2003. Involvement of the prefrontal cortex but not the dorsal hippocampus in the attention-enhancing effects of nicotine in rats. Psychopharmacology 168:271-279.
36. Harvey SC, Maddox FN, Luetje CW. 1996. Multiple determinants of dihydro-beta-erythroidine sensitivity on rat neuronal nicotinic receptor alpha subunits. J Neurochem 67: 1953-1959.
37. Heidbreder CA, Groenewegen HJ. 2003. The medial prefrontal cortex in the rat: Evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci Biobehav Rev 27:555-579.
38. Hellström-Lindahl E, Gorbounova O, Seiger A, Mousavi M, Nordberg A. 1998. Regional distribution of nicotinic receptors during prenatal development of human brain and spinal cord. Brain Res Dev Brain Res 108:147-160.
39. Helmeke C, Ovtscharoff W Jr, Poeggel G, Braun K. 2008. Imbalance of immunohistochemically characterized interneuron populations in the adolescent and adult rodent medial prefrontal cortex after repeated exposure to neonatal separation stress. Neuroscience 152:18-28.
40. Herzog E, Bellenchi GC, Gras C, Bernard V, Ravassard P, Bedet C, Gasnier B, Giros B, El Mestikawy S. 2001. The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons. J Neurosci 21:RC181.
41. Hill JA Jr, Zoli M, Bourgeois JP, Changeux JP. 1993. Immunocytochemical localization of a neuronal nicotinic receptor: The beta 2-subunit. J Neurosci 13:1551-1568.
42. Hof PR, Glezer II, Condé F, Flagg RA, Rubin MB, Nimchinsky EA, Vogt Weisenhorn DM. 1999. Cellular distribution of the calcium-binding proteins parvalbumin, calbindin, and calretinin in the neocortex of mammals: Phylogenetic and developmental patterns. J Chem Neuroanat 16:77-116.
43. Hoover WB, Vertes RP. 2007. Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat. Brain Struct Funct 212:149-179.
44. Howe WM, Ji J, Parikh V, Williams S, Mocaër E, Trocmé-Thibierge C, Sarter M. 2010. Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: Underlying cholinergic mechanisms. Neuropsychopharmacology 35:1391-1401.
45. Hur HE, Zaborsky L. 2005. Vglut2 afferents to the medial prefrontal and primary somatosensory cortices: A combined retrograde tracing in situ hybridization. J Comp Neurol 483:351-373.
46. Jones BE. 2008. Modulation of cortical activation and behavioural arousal by cholinergic and orexinergic systems. Ann N Y Acad Sci 1129:26-34.
47. Kargo WJ, Szatmary B, Nitz DA. 2007. Adaptation of prefrontal cortical firing patterns and their fidelity to changes in action-reward contingencies. J Neurosci 27:3548-3559.
48. Kassam SM, Herman PM, Goodfellow NM, Alves NC, Lambe EK. 2008. Developmental excitation of corticothalamic neurons by nicotinic acetylcholine receptors. J Neurosci 28:8756-8764.
49. Kawai HD, Kang HA, Metherate R. 2011. Heightened nicotinic regulation of auditory cortex during adolescence. J Neurosci 31:14367-14377.
50. Khiroug SS, Harkness PC, Pamb PW, Sudweeks SN, Khiroug L, Millar NS, Yakel JL. 2002. Rat nicotinic ACh receptor α7 and β2 subunits co-assemble to form functional heteromeric nicotinic receptor channels. J Physiol 540:425-434.
51. Kirkcaldie MT, Dickson TC, King CE, Grasby D, Riederer BM, Vickens JC. 2002. Neurofilament triplet proteins are restricted to a subset of neurons in the rat neocortex. J Chem Neuroanat 24:163--171.
52. Klaassen A, Glykys J, Maguire J, Labarca C, Mody I, Boulter J. 2006. Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy. Proc Natl Acad Sci U S A 103:19152-19157.
53. Lambe EK, Picciotto MR, Aghajanian GK. 2003. Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharmacology 28:216-225.
54. Lendvai B, Vizi ES. 2008. Nonsynaptic chemical transmission through nicotinic acetylcholine receptors. Physiol Rev 88:333-340.
55. Li P, Steinbach JH. 2010. The neuronal nicotinic alpha4beta2 receptor has a high maximal probability of being open. Br J Pharmacol 160:1906-1915.
56. Liguez-Lecznar M, Skangiel-Kramska J. 2007. Vesicular glutamate transporters VGLUT1 and VGLUT2 in the developing mouse barrel cortex. Int J Dev Neurosci 25:107-114.
57. Liu Q, Huang Y, Xue F, Simard A, DeChon J, Li G, Zhang J, Lucero L, Wang M, Sierks M, Hu G, Chang Y, Lukas RJ, Wu J. 2009. A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides. J Neurosci 29: 918-929.
58. Marchi M, Grilli M. 2010. Presynaptic nicotinic receptors modulating neurotransmitter release in the central nervous system: Functional interactions with other coexisting receptors. Prog Neurobiol 92:105-111.
59. Marchi M, Risso F, Viola C, Cavazzani P, Raiteri M. 2002. Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals. J Neurochem 80:1071-1080.
60. Minelli A, Edwards RH, Manzoni T, Conti F. 2003. Postnatal development of the glutamate vesicular transporter VGLUT1 in rat cerebral cortex. Brain Res Dev Brain Res 140:309-314.
61. Mogg AJ, Jones FA, Pullar IA, Sharples CG, Wonnacott S. 2004. Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380. Neuropharmacology 47:848-859.
62. Moser N, Mechawar N, Jones I, Gochberg-Sarver A, Orr-Urtreger A, Plomann M, Salas R, Molles B, Marubio L, Roth U, Maskos U, Winzer-Serhan U, Bourgeois JP, Le Sourd AM, De Biasi M, Schröder H, Lindstrom J, Maelicke A, Changeux JP, Wevers A. 2007. Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures. J Neurochem 102:479-492.
63. Mukhin AG, Gündisch D, Horti AG, Koren AO, Tamagnan G, Kimes AS, Chambers J, Vaupel DB, King SL, Picciotto MR, Innis RB, London ED. 2000. 5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors. Mol Pharmacol 57:642-649.
64. Mura E, Zappettini S, Preda S, Biundo F, Lanni C, Grilli M, Cavallero A, Olivero G, Salamone A, Govoni S, Marchi M. 2012. Dual effect of beta-amyloid on α7 and α4β2 nicotinic receptors controlling the release of glutamate, aspartate and GABA in rat hippocampus. PLoS One 7: e29661.
65. Murray TA, Bertrand D, Papke RL, George AA, Pantoja R, Srinivasan R, Liu Q, Wu J, Whiteaker P, Lester HA, Lukas RJ. 2012. α7β2 Nicotinic acetylcholine receptors assemble, function, and are activated primarily via their α7-α7 interfaces. Mol Pharmacol 81:175-188.
66. Nakamura K, Hioki H, Fujiyama F, Kaneko T. 2005. Postnatal changes of vesicular glutamate transporter VGluT1 and VGluT2 immunoreactivities and their colocalization in the mouse forebrain. J Comp Neurol 492:263-288.
67. Nakayama H, Shioda S, Okuda H, Nakashima T, Nakai Y. 1995. Immunocytochemical localization of nicotinic acetylcholine receptor in rat cerebral cortex. Brain Res Mol Brain Res 32:321-328.
68. Nashmi R, Dickinson ME, McKinney S, Jareb M, Labarca C, Fraser SE, Lester HA. 2003. Assembly of alpha4beta2 nicotinic acetylcholine receptors assessed with functional fluorescently labeled subunits: Effects of localization, trafficking, and nicotine-induced upregulation in clonal mammalian cells and in cultured midbrain neurons. J Neurosci 23:11554-11567.
69. Nelson ME, Kuryatov A, Choi CH, Zhou Y, Lindstrom J. 2003. Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors. Mol Pharmacol 63:332-341.
70. Palomero-Gallagher N, Zilles K. 2004. Isocortex. In: Paxinos G, editor. The rat nervous system. Amsterdam: Elsevier Academic Press. p 729-753.
71. Parikh V, Kozak R, Martinez V, Sarter M. 2007. Prefrontal acetylcholine release controls cue detection on multiple timescales. Neuron 56:141-154.
72. Paulussen M, Jacobs S, Van der Gucht E, Hof PR, Arckens L. 2011. Cytoarchitecture of the mouse neocortex revealed by the low-molecular-weight neurofilament protein subunit. Brain Struct Funct 216:183-199.
73. Paxinos G, Franklin KBJ. 2001. The mouse brain in stereotaxic coordinates. San Diego, CA: Academic Press.
74. Perez-Cruz C, Müller-Keuker JI, Heilbronner U, Fuchs E, Flügge G. 2007. Morphology of pyramidal neurons in the rat prefrontal cortex: Lateralized dendritic remodeling by chronic stress. Neural Plast 2007:46276.
75. Phillips HA, Favre I, Kirkpatrick M, Zuberi SM, Goudie D, Heron SE, Scheffer IE, Sutherland GR, Berkovic SF, Bertrand D, Mulley JC. 2001. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am J Hum Genet 68:225-231.
76. Picard F, Brodtkorb E. 2008. Familial frontal lobe epilepsy. In: Engel J Jr, Pedley TA, editors. Epilepsy. A comprehensive textbook. Philadelphia, PA: Lippincott Williams and Wilkins. p 2495-2502.
77. Poorthuis RB, Bloem B, Schak B, Wester J, de Kock CP, Mansvelder HD. 2012. Layer-specific modulation of the prefrontal cortex by nicotinic acetylcholine receptors. Cereb Cortex 23:148-161.
78. Porter JT, Cauli B, Tsuzuki K, Lambolez B, Rossier J, Audinat E. 1999. Selective excitation of subtypes of neocortical interneurons by nicotinic receptors. J Neurosci 19:5228-5235.
79. Quik M, Polonskaya Y, Gillespie A, Jakowec M, Lloyd GK, Langston JW. 2000. Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization. J Comp Neurol 425:58-69.
80. Quik M, Wonnacott S. 2011. α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease. Pharmacol Rev 63:938-966.
81. Raju DV, Shah DJ, Wright TM, Hall RA, Smith Y. 2006. Differential synaptology of vGluT2-containing thalamostriatal afferents between the patch and matrix compartments in rats. J Comp Neurol 499:231-243.
82. Remple MS, Reed JL, Stepniewska I, Lyon DC, Kaas JH. 2007. The organization og frontoparietal cortex in the tree shrew (Tupaia belangeri): II Connectional evidence for a frontal-posterior parietal network. J Comp Neurol 501:121-149.
83. Richardson KA, Fanselow EE, Connors BW. 2008. Neocortical anatomy and physiology. In: Engel J Jr, Pedley TA, editors. Epilepsy. A comprehensive textbook. Philadelphia, PA: Lippincott Williams and Wilkins. p 323-335.
84. Sarter M, Gehring WJ, Kozak R. 2006. More attention must be paid: The neurobiology of attentional effort. Brain Res Rev 51:145-160.
85. Schneider M, Koch M. 2005. Behavioral and morphological alterations following neonatal excitotoxic lesions of the neonatal prefrontal cortex in rats. Exp Neurol 195:185-198.
86. Schröder H. 1992. Immunohistochemistry of cholinergic receptors. Anat Embryol 186:407-429.
87. Shepherd GMG. 2009. Intracortical cartography in an agranular area. Front Neurosci 3:337-343.
88. Sihver W, Gillberg PG, Nordberg A. 1998. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytosine and [3H]epibatidine in vitro autoradiography. Neuroscience 85:1121-1133.
89. Soriano E, Del Rio JA, Ferrer I, Auladell C, De Lecea L, Alcantara S. 1992. Late appearance of parvalbumin-immunoreactive neurons in the rodent cerebral cortex does not follow an 'inside-out' sequence. Neurosci Lett 142:147-150.
90. Steinlein OK, Mulley JC, Propping P, Wallace RH, Phillips HA, Sutherland GR, Scheffer IE, Berkovic SF. 1995. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 11:201-203.
91. Uylings HB, Groenewegen HJ, Kolb B. 2003. Do rats have a prefrontal cortex? Behav Brain Res 146:3-17.
92. Van de Werd HJ, Rajkowska G, Evers P, Uylings HB. 2010. Cytoarchitectonic and chemoarchitectonic characterization of the prefrontal cortical areas in the mouse. Brain Struct Funct 214:339-353.
93. Vidal C, Changeux JP. 1993. Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortex in vitro. Neuroscience 56:23-32.
94. Whiteaker P, Cooper JF, Salminen O, Marks MJ, McClure-Begley TD, Brown RW, Collins AC, Lindstrom JM. 2006. Immunolabeling demonstrates the interdependence of mouse brain alpha4 and beta2 nicotinic acetylcholine receptor subunit expression. J Comp Neurol 499:1016-1038.
95. Williams DK, Wang J, Papke RL. 2011. Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: Advantages and limitations. Biochem Pharmacol 82:915-930.
96. Wong TP, Marchese G, Casu MA, Ribeiro-da-Silva A, Cuello AC, De Koninck Y. 2000. Loss of presynaptic and postsynaptic structures is accompanied by compensatory increase in action potential-dependent synaptic input to layer V neocortical pyramidal neurons in aged rats. J Neurosci 20:8596-8606.
97. Xiang Z, Huguenard JR, Prince DA. 1998. Cholinergic switching within neocortical inhibitory networks. Science 281:985-988.
98. Zappettini S, Grilli M, Salamone A, Fedele E, Marchi M. 2010. Pre-synaptic nicotinic receptors evoke endogenous glutamate and aspartate release from hippocampal synaptosomes by way of distinct coupling mechanisms. Br J Pharmacol 161:1161-1171.
99. Zarghooni S, Wunsch J, Bodenbenner M, Brüggmann D, Grando SA, Schwantes U, Wess J, Kummer W, Lips KS. 2007. Expression of muscarinic and nicotinic acetylcholine receptors in the mouse urothelium. Life Sci 80:2308-2313.
100. Zolles G, Wagner E, Lampert A, Sutor B. 2009. Functional expression of nicotinic acetylcholine receptors in rat neocortical layer 5 pyramidal cells. Cereb Cortex 19:1079-1091.
101. Zwart R, Vijverberg HP. 1997. Potentiation and inhibition of neuronal nicotinic receptors by atropine: Competitive and noncompetitive effects. Mol Pharmacol 52:886-895.
102. Zwart R, Broad LM, Xi Q, Lee M, Moroni M, Bermudez I, Sher E. 2006. 5-I-A-85380 and TC-2559 differentially activate heterologously expressed α4β2 nicotinic receptors. Eur J Pharmacol 539:10-17.